ZA200303601B - Compositions of N-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides. - Google Patents

Compositions of N-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides.

Info

Publication number: ZA200303601B
Authority: ZA; South Africa
Prior art keywords: pyridylsulfonamide; methylethylaminocarbonyl; methylphenylamino; compositions; cyclic oligosaccharides
Prior art date: 2000-11-10

Application number

ZA200303601A

Other languages

English (en)

Inventor

Miljenko Domic

Filic Darko Klepic Bozena

Aleksandar Danilovski

Marijan Tudja

Original Assignee

Pliva Pharm & Chem Works

Farmaceutska Ind

Dionicko Drustvo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-10

Filing date

2001-01-31

Publication date

2004-07-19

2001-01-31 Application filed by Pliva Pharm & Chem Works, Farmaceutska Ind, Dionicko Drustvo filed Critical Pliva Pharm & Chem Works

2004-07-19 Publication of ZA200303601B publication Critical patent/ZA200303601B/xx

Links

KMYFTLHVDUDUPD-UHFFFAOYSA-N 1-ethyl-1-methyl-3-[4-(3-methylanilino)pyridin-3-yl]sulfonylurea Chemical group CCN(C)C(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC=CC(C)=C1 KMYFTLHVDUDUPD-UHFFFAOYSA-N 0.000 title 1
-1 cyclic oligosaccharides Chemical class 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229920001542 oligosaccharide Polymers 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Nanotechnology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Medical Informatics (AREA)
Biophysics (AREA)
Crystallography & Structural Chemistry (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

ZA200303601A 2000-11-10 2001-01-31 Compositions of N-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides. ZA200303601B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HR20000765A HRP20000765A2 (en)	2000-11-10	2000-11-10	Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release

Publications (1)

Publication Number	Publication Date
ZA200303601B true ZA200303601B (en)	2004-07-19

Family

ID=10947206

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200303601A ZA200303601B (en)	2000-11-10	2001-01-31	Compositions of N-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides.

Country Status (26)

Country	Link
US (1)	US7037928B2 (cs)
EP (1)	EP1347780B1 (cs)
JP (1)	JP2004513155A (cs)
KR (1)	KR20030060929A (cs)
CN (1)	CN1477977A (cs)
AR (1)	AR026815A1 (cs)
AU (1)	AU2001228721A1 (cs)
BG (1)	BG107896A (cs)
BR (1)	BR0115281A (cs)
CA (1)	CA2428179A1 (cs)
CZ (1)	CZ20031490A3 (cs)
DE (1)	DE60125828T2 (cs)
EA (1)	EA005111B1 (cs)
EE (1)	EE200300197A (cs)
GE (1)	GEP20043403B (cs)
HR (1)	HRP20000765A2 (cs)
HU (1)	HUP0400776A2 (cs)
IL (1)	IL155818A0 (cs)
IS (1)	IS6810A (cs)
MX (1)	MXPA03004111A (cs)
NO (1)	NO20032091L (cs)
PL (1)	PL361667A1 (cs)
SK (1)	SK6722003A3 (cs)
WO (1)	WO2002038186A1 (cs)
YU (1)	YU35303A (cs)
ZA (1)	ZA200303601B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI21703A (en) *	2004-01-14	2005-08-31	Lek Farmacevtska Druzba Dd	Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
CA2553789C (en) *	2004-01-22	2011-07-19	Pfizer Inc.	Sulfonamide derivatives for the treatment of diseases
CN100372534C (zh) *	2006-04-20	2008-03-05	南京海辰药业有限公司	托拉塞米冻干制剂及制备方法
EP2155195B1 (en)	2007-04-13	2014-07-16	Millennium Pharmaceuticals, Inc.	Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
BR102012009317B1 (pt) *	2012-04-20	2022-05-31	Universidade Federal De Minas Gerais - Ufmg	Processo de preparação de compostos de inclusão envolvendo ciclodextrinas e fármacos, usando um sistema de fluxo contínuo
ES2984026T3 (es) *	2015-06-16	2024-10-28	Atxa Therapeutics Ltd	Antagonistas del receptor de tromboxano
ES3041602T3 (en)	2018-12-10	2025-11-13	Sq Innovation Ag	Pharmaceutical compositions of furosemide and uses thereof
ES3058386T3 (es)	2019-01-04	2026-03-10	Sq Innovation Ag	Composiciones farmacéuticas de furosemida
EP3906020B1 (en) *	2019-01-04	2025-12-31	SQ Innovation AG	Pharmaceutical compositions of torsemide and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US576511A (en) *		1897-02-02		Georg steinike and friedrich schmidt
DE3529529A1 (de) *	1985-08-17	1987-02-19	Boehringer Mannheim Gmbh	Verfahren zur herstellung einer stabilen modifikation von torasemid
CN1123236C (zh) *	1995-12-01	2003-10-01	皇家菲利浦电子有限公司	数字无绳电话系统、无线基站
US6828334B2 (en) *	2002-05-23	2004-12-07	Usv Limited	Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition

2000
- 2000-11-10 HR HR20000765A patent/HRP20000765A2/hr not_active Application Discontinuation
2001
- 2001-01-09 AR ARP010100079A patent/AR026815A1/es not_active Application Discontinuation
- 2001-01-31 PL PL01361667A patent/PL361667A1/xx unknown
- 2001-01-31 US US10/416,303 patent/US7037928B2/en not_active Expired - Fee Related
- 2001-01-31 EE EEP200300197A patent/EE200300197A/xx unknown
- 2001-01-31 AU AU2001228721A patent/AU2001228721A1/en not_active Abandoned
- 2001-01-31 GE GE5156A patent/GEP20043403B/en unknown
- 2001-01-31 ZA ZA200303601A patent/ZA200303601B/xx unknown
- 2001-01-31 SK SK672-2003A patent/SK6722003A3/sk unknown
- 2001-01-31 IL IL15581801A patent/IL155818A0/xx unknown
- 2001-01-31 CA CA002428179A patent/CA2428179A1/en not_active Abandoned
- 2001-01-31 CN CNA018198309A patent/CN1477977A/zh active Pending
- 2001-01-31 YU YU35303A patent/YU35303A/sh unknown
- 2001-01-31 EA EA200300556A patent/EA005111B1/ru not_active IP Right Cessation
- 2001-01-31 WO PCT/HR2001/000004 patent/WO2002038186A1/en not_active Ceased
- 2001-01-31 DE DE60125828T patent/DE60125828T2/de not_active Expired - Fee Related
- 2001-01-31 KR KR10-2003-7006357A patent/KR20030060929A/ko not_active Withdrawn
- 2001-01-31 CZ CZ20031490A patent/CZ20031490A3/cs unknown
- 2001-01-31 EP EP01993478A patent/EP1347780B1/en not_active Expired - Lifetime
- 2001-01-31 JP JP2002540768A patent/JP2004513155A/ja active Pending
- 2001-01-31 BR BR0115281-5A patent/BR0115281A/pt not_active IP Right Cessation
- 2001-01-31 MX MXPA03004111A patent/MXPA03004111A/es unknown
- 2001-01-31 HU HU0400776A patent/HUP0400776A2/hu unknown
2003
- 2003-05-08 IS IS6810A patent/IS6810A/is unknown
- 2003-05-09 NO NO20032091A patent/NO20032091L/no not_active Application Discontinuation
- 2003-06-10 BG BG107896A patent/BG107896A/bg unknown

Also Published As

Publication number	Publication date
KR20030060929A (ko)	2003-07-16
BR0115281A (pt)	2003-07-29
CZ20031490A3 (cs)	2003-08-13
DE60125828T2 (de)	2007-08-16
IS6810A (is)	2003-05-08
SK6722003A3 (en)	2003-10-07
HRP20000765A2 (en)	2002-06-30
DE60125828D1 (de)	2007-02-15
EP1347780A1 (en)	2003-10-01
IL155818A0 (en)	2003-12-23
CN1477977A (zh)	2004-02-25
EE200300197A (et)	2003-08-15
YU35303A (sh)	2006-03-03
BG107896A (bg)	2004-01-30
AU2001228721A1 (en)	2002-05-21
NO20032091D0 (no)	2003-05-09
WO2002038186A1 (en)	2002-05-16
US20040039204A1 (en)	2004-02-26
MXPA03004111A (es)	2004-05-05
GEP20043403B (en)	2004-06-10
NO20032091L (no)	2003-07-02
CA2428179A1 (en)	2002-05-16
EA005111B1 (ru)	2004-10-28
PL361667A1 (en)	2004-10-04
HUP0400776A2 (hu)	2004-08-30
US7037928B2 (en)	2006-05-02
EA200300556A1 (ru)	2003-08-28
EP1347780B1 (en)	2007-01-03
JP2004513155A (ja)	2004-04-30
AR026815A1 (es)	2003-02-26

Publication	Publication Date	Title
HUP0300203A3 (en)	2006-01-30	Novel cyclic amide derivatives, and pharmaceutical compositions containing same
HUP0303825A3 (en)	2005-06-28	1h-benzimidazole and 3h-imidazo-[4,5b]pyridine-derivatives, their use and pharmaceutical compositions containing them
AU8670901A (en)	2002-03-13	Fabric care compositions comprising cationic silicones and methods employing same
HUP0301146A3 (en)	2004-08-30	2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use
HUP0303621A3 (en)	2005-03-29	Pharmaceutical compositions containing combinations comprising an antidiarrheal agent and epothilone or an epothilone
HUP0302893A3 (en)	2006-04-28	Non-imidazole aryloxypiperidines and pharmaceutical compositions containing them and their use
EP1251953A4 (en)	2007-09-26	MODIFIED RHEOLOGY COMPOSITIONS AND MODIFICATION AGENTS
DZ3313A1 (fr)	2001-09-07	Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
IL155841A0 (en)	2003-12-23	Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing same
HUP0402003A3 (en)	2005-06-28	Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
ZA200101821B (en)	2002-09-05	Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection.
IL195166A0 (en)	2009-08-03	Interferons, uses and compositions related thereto
HUP0400967A3 (en)	2004-10-28	Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them
GB0122854D0 (en)	2001-11-14	Dynamic damper and dynamic damper-installed racket
HUP0400179A3 (en)	2004-10-28	2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
IL155818A0 (en)	2003-12-23	Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridyl-sulfonamide and cyclic oligosaccharides
SG100745A1 (en)	2003-12-26	Ceramic composition and ceramic capacitor
AU2001257457A1 (en)	2001-12-24	Vibration dampening compositions and methods thereof
DE60105565D1 (de)	2004-10-21	Stabiles und wirksames weiches feststoffprodukt
HUP0401733A3 (en)	2009-06-29	Cyclic amine-derivatives and pharmaceutical compositions containing them
EG23929A (en)	2008-01-14	Isoxazolines derivatives and their use as antidepressants
HUP0401644A3 (en)	2008-03-28	Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
HUP0204554A3 (en)	2005-05-30	Endoparasiticidal composition, preparation and use thereof
AU3022201A (en)	2001-09-24	Novel use of (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)- chromane and its physiologically aceptable salts
IL156174A (en)	2008-11-03	1,2,4-oxadiazole derivatives and pharmaceutical compositions containing them